Las Vegas, NV -- (SBWIRE) -- 01/17/2014 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks: PV ENTERPRISES (OTCMKTS:PVEC), Lenovo Group Limited (ADR) (OTCMKTS:LNVGY), Centrica PLC (ADR) (OTCMKTS:CPYYY), Generex Biotechnology Corporation (OTCMKTS:GNBT).
PV ENTERPRISES (OTCMKTS:PVEC) ended lower -20.00% and complete the day at $0.00. The total number of shares changed hands during the day was 244.67 million. PV Enterprises International Inc. operates as a regional cruise and charter holding company. It is involved in cruise ship and ferry operations.
Has PVEC Found The Bottom and Ready To Move Up? Find Out Here
Lenovo Group Limited (ADR) (OTCMKTS:LNVGY) closed yesterday at $26.80, a 4.40% increase. Around 77.847.00 shares were traded, beating an-average trading volume of 51,456.00 shares. The company is now valued at around $13.93 billion. Lenovo Group Limited, together with its subsidiaries, engages in the manufacture and distribution of IT products, and provision of IT services in worldwide.
For How Long LNVGY’s Gloss will Attract Investors? Find out via this report
Centrica PLC (ADR) (OTCMKTS:CPYYY) moved 1.73 percent higher at $21.22 and traded between $21.08 and $21.22 after opening the day at $21.13. Its performance over the last five days remained -7.21%, which stands at 0.57% for a month. Going back further than one month, 1-year performance after recent close was -3.33%. Centrica plc operates as an integrated energy company. The company’s British Gas segment engages in the supply of gas and electricity to 12 million homes in the United Kingdom; provides installation, repair, and maintenance services for central heating, plumbing and drains.
For How Long CPYYY’s Gloss will Attract Investors? Find out via this report
Generex Biotechnology Corporation (OTCMKTS:GNBT)’s shares fall, losing -1.18 percent to close at $0.0420. The stock is up around 46.85% this year and 25.75% for the last 12 months. Around 4.11 million shares changed hands yesterday, lower from an-average trading volume of 5.57 million shares. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Will GNBT Get Buyers Even After The Recent Rally? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)